Cellino’s Path Towards Personalized Cell Therapies at Scale
Meet Cellino, a Leaps portfolio company that aims to make personalized cell therapies available at scale through advanced manufacturing. Founder and CEO Nabiha Saklayen shares her insight into the potential of cell therapies to change the course or even cure some of the most challenging diseases. Cellino’s unique interdisciplinary approach aims to automate the manufacturing […]
Escend Pharmaceuticals, Inc., Receives IND Clearance from the FDA for ES-3000 Phase I Study in Relapsed or Refractory Acute Myeloid Leukemia (AML)
MENLO PARK, Calif., July 15, 2022 /PRNewswire/ — Escend Pharmaceuticals, Inc., a privately held company focused on the development of small molecule therapeutics for oncology orphan diseases, announced today that the United States Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application for its lead drug candidate, ES-3000 for a Phase I […]
Stem cells saving lives from heart birth defects
Stems Cells are being used to help revitalize the hearts of babies who suffer from a severe heart defect and sometimes prevent the need for a transplant. Video Transcript: Almost 1 out of 100 babies is born with a heart defect. Each year in the U.S. many of these babies will need surgery within weeks […]
Global Induced Pluripotent Stem Cell (iPSC) Market Report 2022: Vast Potential in Cell Therapy, Disease Modelling, Drug Development and Discovery, Personalized Medicine & Toxicology Testing
DUBLIN, July 13, 2022 /PRNewswire/ — The “Global Induced Pluripotent Stem Cell (iPSC) Industry Report, 2022” report has been added to ResearchAndMarkets.com’s offering. Since the discovery of induced pluripotent stem cell (iPSC) technology in 2006, significant progress has been made in stem cell biology and regenerative medicine. New pathological mechanisms have been identified and explained, new […]
Understanding Human Pluripotent Stem Cell States and Their Applications with Thorold Theunissen
Thorold Theunissen, Ph.D., of the Washington University School of Medicine in St. Louis shares his work using naive stem cells to model trophoblast development. Video Transcript: [MUSIC] My lab studies human pluripotent stem cells. We’re especially interested in understanding different stem cell states and their applications. Recently, we’ve become really excited about using naive stem […]
Akari Therapeutics Announces First Patient to Complete Course of Treatment in the Phase III Part A Clinical Trial of Investigational Nomacopan in Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA)
NEW YORK and LONDON, July 07, 2022 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company focused on developing advanced therapies for autoimmune and inflammatory diseases, today announced that a patient has completed the course of investigational nomacopan treatment in the open-label, multi-center Phase III Part A clinical trial in pediatric hematopoietic stem cell transplant-related […]
“New Treatments for Age-Related Macular Degeneration: Drug, Genes & Stem Cells”-Dr. Marco Zarbin
The invited speaker at the July 5, 2022 meeting of the Old Guard of Summit NJ was Dr. Marco Zarbin who discussed how age-related macular degeneration (AMD) is the leading cause of blindness among persons over 55, and the range of new treatments that are available and coming in the near future. Thirty percent of […]
Stem Cell Therapy – Miracles and Money Wasted
Stem cells have an amazing ability to repair tissue damage. They seem to improve many conditions including Alzheimer’s, arthritis, cardiac disease and much more. But, that potential is luring consumers to spend big money on unproven treatments. HealthCall’s Lee Kelso explores this problem and the potential of stem cell therapy with Dr. Ernst Von Schwarz, […]
ISSCR 2022: On the Ground | The Stem Cell Podcast
In this special episode of the Stem Cell Podcast, Daylon and Arun talk with delegates at the ISSCR 2022 annual meeting. The attendees discuss the memorable research presented and share their thoughts on the challenges facing the stem cell field.
Inceptor Bio Announces Strategic Collaboration with University of Minnesota to Develop Novel iPSC Platform for the Advancement of Next-Generation Allogeneic Cell Therapies
MORRISVILLE, N.C., June 30, 2022 /PRNewswire/ — Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, today announced a collaboration with University of Minnesota. The aim of this collaboration is to build a novel induced pluripotent stem cells (iPSC) platform that will accelerate Inceptor Bio’s best-in-class next-generation cell therapies platforms. Under the terms of […]